Michael Robert Martin - Sep 20, 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Signature
/s/ Michael Robert Martin
Stock symbol
AUPH
Transactions as of
Sep 20, 2021
Transactions value $
-$2,070,975
Form type
4
Date filed
9/22/2021, 04:31 PM
Previous filing
Sep 16, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Options Exercise $151K +28.5K +16.11% $5.30 205K Sep 20, 2021 Direct F1
transaction AUPH Common Shares Sale -$271K -12.5K -6.09% $21.71 193K Sep 20, 2021 Direct F2, F3
transaction AUPH Common Shares Sale -$346K -16K -8.3% $21.60 177K Sep 20, 2021 Direct F4, F5
transaction AUPH Common Stock Options Exercise $39.8K +7.5K +4.24% $5.30 184K Sep 21, 2021 Direct F1
transaction AUPH Common Stock Options Exercise $424K +70K +37.97% $6.06 254K Sep 21, 2021 Direct F1
transaction AUPH Common Stock Options Exercise $184K +10K +3.93% $18.38 264K Sep 21, 2021 Direct F1
transaction AUPH Common Shares Sale -$2.1M -87.5K -33.1% $24.02 177K Sep 21, 2021 Direct F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Option Grant (right to buy) Options Exercise -$151K -28.5K -79.17% $5.30 7.5K Sep 20, 2021 Common Stock 28.5K $5.30 Direct F1, F7
transaction AUPH Option Grant (right to buy) Options Exercise $0 -7.5K -100% $0.00* 0 Sep 21, 2021 Common Stock 7.5K $5.30 Direct F1, F7
transaction AUPH Option Grant (right to buy) Options Exercise $0 -70K -100% $0.00* 0 Sep 21, 2021 Common Stock 70K $6.06 Direct F1, F8
transaction AUPH Option Grant (right to buy) Options Exercise $0 -10K -14.95% $0.00 56.9K Sep 21, 2021 Common Stock 10K $18.38 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.70 to $21.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in connection with a divorce settlement agreement.
F5 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.56 to $21.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F6 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.90 to $24.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7 The shares subject to the option vest in thirty-six equal monthly installments from the grant date.
F8 The shares subject to the option vest in twenty-four equal monthly installments from the grant date.